- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03937635
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Study Overview
Status
Conditions
Detailed Description
PRIMARY OBJECTIVES:
I. To compare overall survival in patients with high-risk smoldering multiple myeloma randomized to daratumumab-lenalidomide (revlimid)-dexamethasone or revlimid-dexamethasone.
SECONDARY OBJECTIVES:
I. To compare progression-free survival and response rates between arms. II. To evaluate safety and compare toxicity rates between arms. III. To monitor incidence of infusion-related reactions over the first cycle of daratumumab.
IV. To evaluate stem cell mobilization failure and early stem cell mobilization feasibility.
EXPLORATORY OBJECTIVES:
I. To measure treatment exposure and adherence. II. To estimate treatment duration and time to progression.
PATIENT-REPORTED OUTCOMES OBJECTIVES:
I. To compare change in health-related quality of life (Functional Assessment of Cancer Therapy [FACT]- General [G]]) from baseline to end of study therapy between arms.
II. To compare change in FACT-G scores from treatment end to 6-months post-treatment end between arms.
III. To describe changes in FACT-G scores over study therapy and shortly after treatment discontinuation and evaluate correlation with survival.
IV. To evaluate attributes of select patient reported treatment-emergent symptomatic adverse events (Patient Reported Outcomes [PRO]-Common Terminology Criteria for Adverse Events [CTCAE]) longitudinally.
V. To derive an overall PRO-CTCAE score at each assessment time point. VI. To measure the likelihood of medication adherence (ASK-12) at 6 month intervals throughout treatment.
VII. To assess the association of overall PRO-CTCAE score with FACT-G score. VIII. To compare select PRO-CTCAE items and related provider-reported CTCAEs. IX. To evaluate association between treatment adherence and Adherence Starts with Knowledge 12 (ASK-12) score.
X. To assess correlation of treatment adherence and ASK-12 score with FACT-G score.
XI. To tabulate PRO compliance and completion rates.
LABORATORY OBJECTIVES:
I. To compare minimal residual disease negative rate after 12 cycles of study therapy between arms.
II. To compare minimal residual disease (MRD) positive to negative conversion rates from 12 cycles to end of treatment between arms.
III. To examine patterns of change in minimal residual disease levels during study therapy.
IV. To evaluate agreement and discordance between methods determining disease-free status.
V. To assess the prognostic value of minimal residual disease status at 12 cycles for overall and progression-free survival.
IMAGING OBJECTIVES:
I. To evaluate the association of baseline fludeoxyglucose F-18 (FDG)-positron emission tomography (PET)/computed tomography (CT) imaging with progression-free survival.
II. To assess the ability of baseline FDG-PET/CT to predict minimal residual disease status after 12 cycles of study therapy and at the end of study therapy.
III. To describe the results of subsequent FDG-PET/CT imaging studies in the subset of patients with baseline abnormal FDG-PET/CT, and to associate these results with progression-free survival (PFS).
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive daratumumab intravenously (IV) on days 1, 8, 15, and 22 of courses 1-2, days 1 and 15 of courses 3-6, and day 1 of courses 7-24. Patients also receive lenalidomide orally (PO) daily on days 1-21 and dexamethasone PO on days 1, 8, 15, and 22 in courses 1-12. Treatment repeats every 28 days for up to 24 courses in the absence of disease progression or unacceptable toxicity.
ARM II: Patients receive lenalidomide PO daily on days 1-21 and dexamethasone PO on days 1, 8, 15, and 22 of courses 1-12. Treatment repeats every 28 days for up to 24 courses in the absence of disease progression or unacceptable toxicity.
After completion of study, patients will be followed up every 3, 6 or 12 months for up to 15 years from study entry.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alaska
-
Anchorage, Alaska, United States, 99504
- Suspended
- Anchorage Radiation Therapy Center
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Alaska Women's Cancer Care
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Katmai Oncology Group
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Providence Alaska Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 98508
- Recruiting
- Anchorage Associates in Radiation Medicine
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Alaska Breast Care and Surgery LLC
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Alaska Oncology and Hematology LLC
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Anchorage, Alaska, United States, 99508
- Recruiting
- Anchorage Oncology Centre
-
Contact:
- Site Public Contact
- Phone Number: 907-212-6871
- Email: AKPAMC.OncologyResearchSupport@providence.org
-
Principal Investigator:
- Alison K. Conlin
-
Fairbanks, Alaska, United States, 99701
- Recruiting
- Fairbanks Memorial Hospital
-
Contact:
- Site Public Contact
- Phone Number: 907-458-3043
- Email: Veronica.Stevenson@foundationhealth.org
-
Principal Investigator:
- Nicholas DiBella
-
-
Arizona
-
Goodyear, Arizona, United States, 85338
- Active, not recruiting
- CTCA at Western Regional Medical Center
-
Kingman, Arizona, United States, 86401
- Suspended
- Kingman Regional Medical Center
-
Phoenix, Arizona, United States, 85004
- Recruiting
- Cancer Center at Saint Joseph's
-
Contact:
- Site Public Contact
- Phone Number: 602-406-0777
- Email: CancerInstitute@DignityHealth.org
-
Principal Investigator:
- Richard L. Deming
-
Phoenix, Arizona, United States, 85054
- Suspended
- Mayo Clinic Hospital in Arizona
-
Scottsdale, Arizona, United States, 85259
- Suspended
- Mayo Clinic in Arizona
-
-
Arkansas
-
Fort Smith, Arkansas, United States, 72903
- Recruiting
- Mercy Hospital Fort Smith
-
Contact:
- Site Public Contact
- Phone Number: 800-378-9373
-
Principal Investigator:
- Jay W. Carlson
-
Hot Springs, Arkansas, United States, 71913
- Recruiting
- CHI Saint Vincent Cancer Center Hot Springs
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 855-313-2409
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
-
California
-
Arroyo Grande, California, United States, 93420
- Recruiting
- PCR Oncology
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Arroyo Grande, California, United States, 93420
- Suspended
- Mission Hope Medical Oncology - Arroyo Grande
-
Burbank, California, United States, 91505
- Recruiting
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 818-847-4793
- Email: Najee.Boucher@providence.org
-
Dublin, California, United States, 94568
- Recruiting
- Epic Care-Dublin
-
Contact:
- Site Public Contact
- Phone Number: 925-875-1677
-
Principal Investigator:
- Lisa Bailey
-
Emeryville, California, United States, 94608
- Recruiting
- Bay Area Breast Surgeons Inc
-
Principal Investigator:
- Lisa Bailey
-
Contact:
- Site Public Contact
- Phone Number: 510-835-9900
-
Emeryville, California, United States, 94608
- Recruiting
- Epic Care Partners in Cancer Care
-
Principal Investigator:
- Lisa Bailey
-
Contact:
- Site Public Contact
- Phone Number: 510-629-6682
-
La Jolla, California, United States, 92093
- Recruiting
- UC San Diego Moores Cancer Center
-
Principal Investigator:
- Caitlin Costello
-
Contact:
- Site Public Contact
- Phone Number: 858-822-5354
- Email: cancercto@ucsd.edu
-
Martinez, California, United States, 94553-3156
- Recruiting
- Contra Costa Regional Medical Center
-
Principal Investigator:
- Lisa Bailey
-
Contact:
- Site Public Contact
- Phone Number: 925-957-5400
-
Oakland, California, United States, 94609
- Recruiting
- Bay Area Tumor Institute
-
Principal Investigator:
- Lisa Bailey
-
Contact:
- Site Public Contact
- Phone Number: 510-465-2242
- Email: lradke@bati.org
-
Oakland, California, United States, 94609
- Recruiting
- Alta Bates Summit Medical Center - Summit Campus
-
Contact:
- Site Public Contact
- Phone Number: 510-204-1414
-
Principal Investigator:
- Lisa Bailey
-
Rancho Mirage, California, United States, 92270
- Recruiting
- Eisenhower Medical Center
-
Principal Investigator:
- Constantin A. Dasanu
-
Contact:
- Site Public Contact
- Phone Number: 760-834-3798
-
San Luis Obispo, California, United States, 93401
- Recruiting
- Pacific Central Coast Health Center-San Luis Obispo
-
Contact:
- Site Public Contact
- Phone Number: 805-219-4673
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Principal Investigator:
- Richard L. Deming
-
Santa Maria, California, United States, 93444
- Recruiting
- Mission Hope Medical Oncology - Santa Maria
-
Contact:
- Site Public Contact
- Phone Number: 805-219-4673
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Principal Investigator:
- Richard L. Deming
-
Walnut Creek, California, United States, 94597
- Recruiting
- Epic Care Cyberknife Center
-
Principal Investigator:
- Lisa Bailey
-
Contact:
- Site Public Contact
- Phone Number: 510-465-8016
- Email: somega@bati.org
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Recruiting
- Rocky Mountain Cancer Centers-Aurora
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Aurora, Colorado, United States, 80012
- Recruiting
- The Medical Center of Aurora
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Boulder, Colorado, United States, 80301
- Recruiting
- Boulder Community Hospital
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: jbloomfield@co-cancerresearch.org
-
Boulder, Colorado, United States, 80304
- Recruiting
- Rocky Mountain Cancer Centers-Boulder
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Centennial, Colorado, United States, 80112
- Suspended
- Rocky Mountain Cancer Centers - Centennial
-
Colorado Springs, Colorado, United States, 80907
- Recruiting
- Penrose-Saint Francis Healthcare
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Colorado Springs, Colorado, United States, 80907
- Recruiting
- Rocky Mountain Cancer Centers-Penrose
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Colorado Springs, Colorado, United States, 80923
- Recruiting
- Saint Francis Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Denver, Colorado, United States, 80218
- Suspended
- SCL Health Saint Joseph Hospital
-
Denver, Colorado, United States, 80220
- Suspended
- Rose Medical Center
-
Denver, Colorado, United States, 80210
- Recruiting
- Porter Adventist Hospital
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Denver, Colorado, United States, 80204
- Suspended
- Cancer Center of Colorado at Sloan's Lake
-
Denver, Colorado, United States, 80209
- Suspended
- The Women's Imaging Center
-
Denver, Colorado, United States, 80218
- Suspended
- Colorado Blood Cancer Institute
-
Denver, Colorado, United States, 80220
- Suspended
- Western Surgical Care
-
Denver, Colorado, United States, 80218
- Recruiting
- Presbyterian - Saint Lukes Medical Center - Health One
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Denver, Colorado, United States, 80206
- Suspended
- National Jewish Health-Main Campus
-
Denver, Colorado, United States, 80218
- Suspended
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, United States, 80220
- Suspended
- Rocky Mountain Cancer Centers-Rose
-
Durango, Colorado, United States, 81301
- Suspended
- Mercy Medical Center
-
Durango, Colorado, United States, 81301
- Suspended
- Southwest Oncology PC
-
Englewood, Colorado, United States, 80113
- Recruiting
- Mountain Blue Cancer Care Center - Swedish
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Englewood, Colorado, United States, 80113
- Recruiting
- Swedish Medical Center
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Englewood, Colorado, United States, 80113
- Recruiting
- The Melanoma and Skin Cancer Institute
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Email: ryan.weight@theskincancerinstitute.com
-
Golden, Colorado, United States, 80401
- Suspended
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, United States, 81501
- Suspended
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, United States, 80631
- Recruiting
- North Colorado Medical Center
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Lafayette, Colorado, United States, 80026
- Suspended
- Good Samaritan Medical Center
-
Lakewood, Colorado, United States, 80228
- Recruiting
- Saint Anthony Hospital
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Littleton, Colorado, United States, 80122
- Recruiting
- Littleton Adventist Hospital
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Littleton, Colorado, United States, 80120
- Recruiting
- Rocky Mountain Cancer Centers-Littleton
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Lone Tree, Colorado, United States, 80124
- Suspended
- Rocky Mountain Cancer Centers-Sky Ridge
-
Lone Tree, Colorado, United States, 80124
- Recruiting
- Sky Ridge Medical Center
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Longmont, Colorado, United States, 80501
- Recruiting
- Longmont United Hospital
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Longmont, Colorado, United States, 80501
- Suspended
- Rocky Mountain Cancer Centers-Longmont
-
Loveland, Colorado, United States, 80539
- Recruiting
- McKee Medical Center
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Parker, Colorado, United States, 80138
- Recruiting
- Parker Adventist Hospital
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Pueblo, Colorado, United States, 81004
- Recruiting
- Saint Mary Corwin Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Principal Investigator:
- Richard L. Deming
-
Thornton, Colorado, United States, 80260
- Recruiting
- Rocky Mountain Cancer Centers-Thornton
-
Principal Investigator:
- Nicholas DiBella
-
Contact:
- Site Public Contact
- Phone Number: 303-777-2663
- Email: info@westernstatesncorp.org
-
Thornton, Colorado, United States, 80260
- Suspended
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, United States, 80033
- Suspended
- SCL Health Lutheran Medical Center
-
-
Connecticut
-
Derby, Connecticut, United States, 06418
- Recruiting
- Smilow Cancer Hospital-Derby Care Center
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Fairfield, Connecticut, United States, 06824
- Recruiting
- Smilow Cancer Hospital Care Center-Fairfield
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Glastonbury, Connecticut, United States, 06033
- Recruiting
- Smilow Cancer Hospital Care Center at Glastonbury
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Guilford, Connecticut, United States, 06437
- Recruiting
- Smilow Cancer Hospital Care Center - Guiford
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Hartford, Connecticut, United States, 06105
- Recruiting
- Smilow Cancer Hospital Care Center at Saint Francis
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
New Haven, Connecticut, United States, 06520
- Recruiting
- Yale University
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
New Haven, Connecticut, United States, 06510
- Recruiting
- Smilow Cancer Center/Yale-New Haven Hospital
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
North Haven, Connecticut, United States, 06473
- Recruiting
- Yale-New Haven Hospital North Haven Medical Center
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Orange, Connecticut, United States, 06477
- Recruiting
- Smilow Cancer Hospital-Orange Care Center
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Torrington, Connecticut, United States, 06790
- Recruiting
- Smilow Cancer Hospital-Torrington Care Center
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Trumbull, Connecticut, United States, 06611
- Recruiting
- Smilow Cancer Hospital Care Center-Trumbull
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Waterbury, Connecticut, United States, 06708
- Recruiting
- Smilow Cancer Hospital-Waterbury Care Center
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
Waterford, Connecticut, United States, 06385
- Recruiting
- Smilow Cancer Hospital Care Center - Waterford
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
-
Florida
-
Fort Lauderdale, Florida, United States, 33308
- Recruiting
- Holy Cross Hospital
-
Contact:
- Site Public Contact
- Phone Number: 954-267-7748
-
Principal Investigator:
- Christopher M. Reynolds
-
Weston, Florida, United States, 33331
- Recruiting
- Cleveland Clinic-Weston
-
Principal Investigator:
- Jack Khouri
-
Contact:
- Site Public Contact
- Phone Number: 954-659-5705
- Email: CancerAnswer@ccf.org
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory University Hospital/Winship Cancer Institute
-
Principal Investigator:
- Nisha S. Joseph
-
Contact:
- Site Public Contact
- Phone Number: 404-778-1868
-
Atlanta, Georgia, United States, 30342
- Recruiting
- Emory Saint Joseph's Hospital
-
Principal Investigator:
- Nisha S. Joseph
-
Contact:
- Site Public Contact
- Phone Number: 404-851-7115
-
Savannah, Georgia, United States, 31405
- Recruiting
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Contact:
- Site Public Contact
- Phone Number: 912-819-5704
- Email: underberga@sjchs.org
-
Principal Investigator:
- Grant C. Lewis
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Recruiting
- Saint Luke's Cancer Institute - Boise
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Boise, Idaho, United States, 83706
- Recruiting
- Saint Alphonsus Cancer Care Center-Boise
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- John M. Schallenkamp
-
Caldwell, Idaho, United States, 83605
- Recruiting
- Saint Alphonsus Cancer Care Center-Caldwell
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- John M. Schallenkamp
-
Coeur d'Alene, Idaho, United States, 83814
- Recruiting
- Kootenai Health - Coeur d'Alene
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Emmett, Idaho, United States, 83617
- Suspended
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, United States, 83619
- Recruiting
- Saint Luke's Cancer Institute - Fruitland
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Meridian, Idaho, United States, 83642
- Recruiting
- Idaho Urologic Institute-Meridian
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- John M. Schallenkamp
-
Meridian, Idaho, United States, 83642
- Recruiting
- Saint Luke's Cancer Institute - Meridian
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Nampa, Idaho, United States, 83686
- Recruiting
- Saint Alphonsus Medical Center-Nampa
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Nampa, Idaho, United States, 83686
- Recruiting
- Saint Luke's Cancer Institute - Nampa
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Post Falls, Idaho, United States, 83854
- Recruiting
- Kootenai Clinic Cancer Services - Post Falls
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Sandpoint, Idaho, United States, 83864
- Suspended
- Kootenai Cancer Clinic
-
Twin Falls, Idaho, United States, 83301
- Recruiting
- Saint Luke's Cancer Institute - Twin Falls
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
-
Illinois
-
Aurora, Illinois, United States, 60504
- Recruiting
- Rush - Copley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 630-978-6212
- Email: Cancer.Research@rushcopley.com
-
Principal Investigator:
- Suparna Mantha
-
Burr Ridge, Illinois, United States, 60527
- Suspended
- Loyola Center for Health at Burr Ridge
-
Danville, Illinois, United States, 61832
- Recruiting
- Carle on Vermilion
-
Principal Investigator:
- Suparna Mantha
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
DeKalb, Illinois, United States, 60115
- Recruiting
- Northwestern Medicine Cancer Center Kishwaukee
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Robert M. Eisner
-
Effingham, Illinois, United States, 62401
- Recruiting
- Carle Physician Group-Effingham
-
Principal Investigator:
- Suparna Mantha
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Evanston, Illinois, United States, 60201
- Recruiting
- NorthShore University HealthSystem-Evanston Hospital
-
Contact:
- Site Public Contact
- Phone Number: 847-570-2109
-
Principal Investigator:
- David L. Grinblatt
-
Geneva, Illinois, United States, 60134
- Recruiting
- Northwestern Medicine Cancer Center Delnor
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Robert M. Eisner
-
Glenview, Illinois, United States, 60026
- Recruiting
- NorthShore University HealthSystem-Glenbrook Hospital
-
Contact:
- Site Public Contact
- Phone Number: 847-570-2109
-
Principal Investigator:
- David L. Grinblatt
-
Harvey, Illinois, United States, 60426
- Recruiting
- Ingalls Memorial Hospital
-
Contact:
- Site Public Contact
- Phone Number: 708-915-4673
- Email: clinicaltrials@ingalls.org
-
Principal Investigator:
- Mark F. Kozloff
-
Highland Park, Illinois, United States, 60035
- Recruiting
- NorthShore University HealthSystem-Highland Park Hospital
-
Contact:
- Site Public Contact
- Phone Number: 847-570-2109
-
Principal Investigator:
- David L. Grinblatt
-
Homer Glen, Illinois, United States, 60491
- Suspended
- Loyola Medicine Homer Glen
-
Joliet, Illinois, United States, 60435
- Active, not recruiting
- Duly Health and Care Joliet
-
Mattoon, Illinois, United States, 61938
- Recruiting
- Carle Physician Group-Mattoon/Charleston
-
Principal Investigator:
- Suparna Mantha
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Maywood, Illinois, United States, 60153
- Recruiting
- Loyola University Medical Center
-
Principal Investigator:
- Patrick A. Hagen
-
Contact:
- Site Public Contact
- Phone Number: 708-226-4357
-
Melrose Park, Illinois, United States, 60160
- Suspended
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb
-
Mount Vernon, Illinois, United States, 62864
- Recruiting
- Good Samaritan Regional Health Center
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 618-242-4600
-
Niles, Illinois, United States, 60714
- Recruiting
- Illinois Cancer Specialists-Niles
-
Contact:
- Site Public Contact
- Phone Number: 847-827-9060
-
Principal Investigator:
- Leonard M. Klein
-
Skokie, Illinois, United States, 60076
- Suspended
- North Shore Medical Center
-
Urbana, Illinois, United States, 61801
- Recruiting
- Carle Cancer Center
-
Principal Investigator:
- Suparna Mantha
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Urbana, Illinois, United States, 61801
- Recruiting
- The Carle Foundation Hospital
-
Principal Investigator:
- Suparna Mantha
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Warrenville, Illinois, United States, 60555
- Recruiting
- Northwestern Medicine Cancer Center Warrenville
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Robert M. Eisner
-
Yorkville, Illinois, United States, 60560
- Suspended
- Rush-Copley Healthcare Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Indiana University/Melvin and Bren Simon Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 317-278-5632
- Email: iutrials@iu.edu
-
Principal Investigator:
- Rafat Abonour
-
Indianapolis, Indiana, United States, 46290
- Suspended
- Springmill Medical Center
-
Richmond, Indiana, United States, 47374
- Recruiting
- Reid Health
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
-
Iowa
-
Ames, Iowa, United States, 50010
- Recruiting
- Mary Greeley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 515-956-4132
-
Principal Investigator:
- Debra M. Prow
-
Ames, Iowa, United States, 50010
- Recruiting
- McFarland Clinic PC - Ames
-
Principal Investigator:
- Debra M. Prow
-
Contact:
- Site Public Contact
- Phone Number: 515-239-4734
- Email: ksoder@mcfarlandclinic.com
-
Boone, Iowa, United States, 50036
- Suspended
- McFarland Clinic PC-Boone
-
Carroll, Iowa, United States, 51401
- Recruiting
- Saint Anthony Regional Hospital
-
Contact:
- Site Public Contact
- Phone Number: 515-689-7658
- Email: sbenson@iora.org
-
Principal Investigator:
- Joshua Lukenbill
-
Clive, Iowa, United States, 50325
- Recruiting
- Medical Oncology and Hematology Associates-West Des Moines
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
Clive, Iowa, United States, 50325
- Recruiting
- Mercy Cancer Center-West Lakes
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
Council Bluffs, Iowa, United States, 51503
- Suspended
- Alegent Health Mercy Hospital
-
Creston, Iowa, United States, 50801
- Recruiting
- Greater Regional Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
Des Moines, Iowa, United States, 50309
- Recruiting
- Medical Oncology and Hematology Associates-Des Moines
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-282-2921
-
Des Moines, Iowa, United States, 50314
- Recruiting
- Broadlawns Medical Center
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-282-2200
-
Des Moines, Iowa, United States, 50314
- Recruiting
- Mercy Medical Center - Des Moines
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
Des Moines, Iowa, United States, 50309
- Recruiting
- Iowa Methodist Medical Center
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-241-6727
-
Des Moines, Iowa, United States, 50316
- Recruiting
- Iowa Lutheran Hospital
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-241-8704
-
Des Moines, Iowa, United States, 50314
- Recruiting
- Medical Oncology and Hematology Associates-Laurel
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
Fort Dodge, Iowa, United States, 50501
- Suspended
- Trinity Regional Medical Center
-
Fort Dodge, Iowa, United States, 50501
- Suspended
- McFarland Clinic PC-Trinity Cancer Center
-
Jefferson, Iowa, United States, 50129
- Suspended
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, United States, 50158
- Suspended
- McFarland Clinic PC-Marshalltown
-
West Des Moines, Iowa, United States, 50266
- Recruiting
- Mercy Medical Center-West Lakes
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-643-2196
- Email: cancerresearch@mercydesmoines.org
-
West Des Moines, Iowa, United States, 50266-7700
- Recruiting
- Methodist West Hospital
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-343-1000
-
-
Kansas
-
Garden City, Kansas, United States, 67846
- Recruiting
- Central Care Cancer Center - Garden City
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 913-948-5588
- Email: aroland@kccop.org
-
Great Bend, Kansas, United States, 67530
- Recruiting
- Central Care Cancer Center - Great Bend
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 913-948-5588
- Email: aroland@kccop.org
-
Overland Park, Kansas, United States, 66213
- Suspended
- Saint Luke's South Hospital
-
Topeka, Kansas, United States, 66606
- Recruiting
- Cotton O'Neil Cancer Center / Stormont Vail Health
-
Principal Investigator:
- Muhammad A. Salamat
-
Contact:
- Site Public Contact
- Phone Number: 785-270-4939
-
-
Kentucky
-
Bardstown, Kentucky, United States, 40004
- Suspended
- Flaget Memorial Hospital
-
Corbin, Kentucky, United States, 40701
- Suspended
- Commonwealth Cancer Center-Corbin
-
Lexington, Kentucky, United States, 40509
- Recruiting
- Saint Joseph Hospital East
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 859-629-7169
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Lexington, Kentucky, United States, 40504
- Recruiting
- Saint Joseph Radiation Oncology Resource Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 859-629-7169
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
London, Kentucky, United States, 40741
- Suspended
- Saint Joseph London
-
Louisville, Kentucky, United States, 40215
- Suspended
- Saints Mary and Elizabeth Hospital
-
Louisville, Kentucky, United States, 40202
- Recruiting
- The James Graham Brown Cancer Center at University of Louisville
-
Principal Investigator:
- Mohamed M. Hegazi
-
Contact:
- Site Public Contact
- Phone Number: 502-562-3429
-
Louisville, Kentucky, United States, 40202
- Recruiting
- Jewish Hospital
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 859-629-7169
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Louisville, Kentucky, United States, 40245
- Recruiting
- Jewish Hospital Medical Center Northeast
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 859-629-7169
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Shepherdsville, Kentucky, United States, 40165
- Suspended
- Jewish Hospital Medical Center South
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70809
- Suspended
- Hematology/Oncology Clinic PLLC
-
Monroe, Louisiana, United States, 71202
- Suspended
- Ochsner LSU Health Monroe Medical Center
-
New Orleans, Louisiana, United States, 70121
- Recruiting
- Ochsner Medical Center Jefferson
-
Principal Investigator:
- Carter T. Davis
-
Contact:
- Site Public Contact
- Phone Number: 504-842-8084
- Email: Elisemarie.curry@ochsner.org
-
New Orleans, Louisiana, United States, 70112
- Recruiting
- Tulane University Health Sciences Center
-
Principal Investigator:
- Kendra M. Harris
-
Contact:
- Site Public Contact
- Phone Number: 504-988-6121
-
Shreveport, Louisiana, United States, 71103
- Recruiting
- LSU Health Sciences Center at Shreveport
-
Contact:
- Site Public Contact
- Phone Number: 318-813-1404
- Email: LPost@lsuhsc.edu
-
Principal Investigator:
- Samip Master
-
-
Maryland
-
Baltimore, Maryland, United States, 21229
- Recruiting
- Saint Agnes Hospital
-
Contact:
- Site Public Contact
- Phone Number: 410-368-2910
-
Principal Investigator:
- Carole B. Miller
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Recruiting
- Tufts Medical Center
-
Principal Investigator:
- Raymond L. Comenzo
-
Contact:
- Site Public Contact
- Phone Number: 617-636-5000
- Email: ContactUsCancerCenter@TuftsMedicalCenter.org
-
Springfield, Massachusetts, United States, 01104
- Suspended
- Mercy Medical Center
-
-
Michigan
-
Adrian, Michigan, United States, 49221
- Recruiting
- Hickman Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 517-265-0116
-
Principal Investigator:
- Rex B. Mowat
-
Ann Arbor, Michigan, United States, 48106
- Recruiting
- Saint Joseph Mercy Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Ann Arbor, Michigan, United States, 48109
- Suspended
- University of Michigan Comprehensive Cancer Center
-
Battle Creek, Michigan, United States, 49017
- Recruiting
- Bronson Battle Creek
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Brighton, Michigan, United States, 48114
- Recruiting
- Saint Joseph Mercy Brighton
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Brighton, Michigan, United States, 48114
- Recruiting
- IHA Hematology Oncology Consultants-Brighton
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Brownstown, Michigan, United States, 48183
- Recruiting
- Henry Ford Cancer Institute-Downriver
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
Canton, Michigan, United States, 48188
- Recruiting
- Saint Joseph Mercy Canton
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Canton, Michigan, United States, 48188
- Recruiting
- IHA Hematology Oncology Consultants-Canton
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Caro, Michigan, United States, 48723
- Recruiting
- Caro Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Chelsea, Michigan, United States, 48118
- Recruiting
- Saint Joseph Mercy Chelsea
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Chelsea, Michigan, United States, 48118
- Recruiting
- IHA Hematology Oncology Consultants-Chelsea
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Clarkston, Michigan, United States, 48346
- Suspended
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, United States, 48346
- Suspended
- Newland Medical Associates-Clarkston
-
Clinton Township, Michigan, United States, 48038
- Recruiting
- Henry Ford Macomb Hospital-Clinton Township
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
Dearborn, Michigan, United States, 48126
- Recruiting
- Henry Ford Medical Center-Fairlane
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
Detroit, Michigan, United States, 48236
- Recruiting
- Ascension Saint John Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Detroit, Michigan, United States, 48202
- Recruiting
- Henry Ford Hospital
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
East China Township, Michigan, United States, 48054
- Suspended
- Great Lakes Cancer Management Specialists-Doctors Park
-
Flint, Michigan, United States, 48503
- Recruiting
- Genesys Hurley Cancer Institute
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Flint, Michigan, United States, 48503
- Recruiting
- Hurley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Flint, Michigan, United States, 48503
- Suspended
- Genesee Cancer and Blood Disease Treatment Center
-
Flint, Michigan, United States, 48503
- Suspended
- Genesee Hematology Oncology PC
-
Grand Rapids, Michigan, United States, 49503
- Recruiting
- Helen DeVos Children's Hospital at Spectrum Health
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Grand Rapids, Michigan, United States, 49503
- Recruiting
- Mercy Health Saint Mary's
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Grand Rapids, Michigan, United States, 49503
- Recruiting
- Spectrum Health at Butterworth Campus
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Grosse Pointe Woods, Michigan, United States, 48236
- Suspended
- Michigan Breast Specialists-Grosse Pointe Woods
-
Grosse Pointe Woods, Michigan, United States, 48236
- Suspended
- Academic Hematology Oncology Specialists
-
Grosse Pointe Woods, Michigan, United States, 48236
- Suspended
- Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
-
Jackson, Michigan, United States, 49201
- Recruiting
- Allegiance Health
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
Kalamazoo, Michigan, United States, 49007
- Recruiting
- Bronson Methodist Hospital
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Kalamazoo, Michigan, United States, 49007
- Recruiting
- West Michigan Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Kalamazoo, Michigan, United States, 49048
- Recruiting
- Borgess Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Lansing, Michigan, United States, 48912
- Recruiting
- Sparrow Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Livonia, Michigan, United States, 48154
- Suspended
- Hope Cancer Clinic
-
Livonia, Michigan, United States, 48154
- Recruiting
- Saint Mary Mercy Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Macomb, Michigan, United States, 48044
- Suspended
- Michigan Breast Specialists-Macomb Township
-
Macomb, Michigan, United States, 48044
- Suspended
- Great Lakes Cancer Management Specialists-Macomb Medical Campus
-
Marlette, Michigan, United States, 48453
- Recruiting
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Monroe, Michigan, United States, 48162
- Suspended
- Toledo Clinic Cancer Centers-Monroe
-
Muskegon, Michigan, United States, 49444
- Recruiting
- Mercy Health Mercy Campus
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Niles, Michigan, United States, 49120
- Recruiting
- Lakeland Hospital Niles
-
Principal Investigator:
- Kathleen J. Yost
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
-
Norton Shores, Michigan, United States, 49444
- Recruiting
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Principal Investigator:
- Kathleen J. Yost
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: connie.szczepanek@crcwm.org
-
Novi, Michigan, United States, 48377
- Recruiting
- Henry Ford Medical Center-Columbus
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
Pontiac, Michigan, United States, 48341
- Recruiting
- 21st Century Oncology-Pontiac
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Pontiac, Michigan, United States, 48341
- Recruiting
- Saint Joseph Mercy Oakland
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Pontiac, Michigan, United States, 48341
- Suspended
- Hope Cancer Center
-
Pontiac, Michigan, United States, 48341
- Suspended
- Newland Medical Associates-Pontiac
-
Port Huron, Michigan, United States, 48060
- Suspended
- Huron Medical Center PC
-
Port Huron, Michigan, United States, 48060
- Suspended
- Lake Huron Medical Center
-
Reed City, Michigan, United States, 49677
- Recruiting
- Spectrum Health Reed City Hospital
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Rochester Hills, Michigan, United States, 48309
- Suspended
- Great Lakes Cancer Management Specialists-Rochester Hills
-
Saginaw, Michigan, United States, 48601
- Recruiting
- Ascension Saint Mary's Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Saginaw, Michigan, United States, 48604
- Recruiting
- Oncology Hematology Associates of Saginaw Valley PC
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Saint Joseph, Michigan, United States, 49085
- Recruiting
- Marie Yeager Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Saint Joseph, Michigan, United States, 49085
- Recruiting
- Lakeland Medical Center Saint Joseph
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Shelby, Michigan, United States, 48315
- Suspended
- Henry Ford Macomb Health Center - Shelby Township
-
Sterling Heights, Michigan, United States, 48312
- Suspended
- Bhadresh Nayak MD PC-Sterling Heights
-
Tawas City, Michigan, United States, 48764
- Recruiting
- Ascension Saint Joseph Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Traverse City, Michigan, United States, 49684
- Recruiting
- Munson Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Warren, Michigan, United States, 48093
- Recruiting
- Saint John Macomb-Oakland Hospital
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Warren, Michigan, United States, 48088
- Suspended
- Advanced Breast Care Center PLLC
-
Warren, Michigan, United States, 48093
- Suspended
- Macomb Hematology Oncology PC
-
Warren, Michigan, United States, 48093
- Suspended
- Michigan Breast Specialists-Warren
-
Warren, Michigan, United States, 48093
- Suspended
- Great Lakes Cancer Management Specialists-Macomb Professional Building
-
West Bloomfield, Michigan, United States, 48322
- Recruiting
- Henry Ford West Bloomfield Hospital
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Ding Wang
-
West Branch, Michigan, United States, 48661
- Recruiting
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Wyoming, Michigan, United States, 49519
- Recruiting
- Metro Health Hospital
-
Contact:
- Site Public Contact
- Phone Number: 616-391-1230
- Email: crcwm-regulatory@crcwm.org
-
Principal Investigator:
- Kathleen J. Yost
-
Ypsilanti, Michigan, United States, 48106
- Suspended
- Huron Gastroenterology PC
-
Ypsilanti, Michigan, United States, 48197
- Recruiting
- IHA Hematology Oncology Consultants-Ann Arbor
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
-
Minnesota
-
Aitkin, Minnesota, United States, 56431
- Suspended
- Riverwood Healthcare Center
-
Albert Lea, Minnesota, United States, 56007
- Recruiting
- Mayo Clinic Health System in Albert Lea
-
Principal Investigator:
- Taxiarchis Kourelis
-
Contact:
- Site Public Contact
- Phone Number: 855-776-0015
-
Brainerd, Minnesota, United States, 56401
- Recruiting
- Essentia Health Saint Joseph's Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Burnsville, Minnesota, United States, 55337
- Recruiting
- Fairview Ridges Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Burnsville, Minnesota, United States, 55337
- Recruiting
- Minnesota Oncology - Burnsville
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Cambridge, Minnesota, United States, 55008
- Suspended
- Cambridge Medical Center
-
Coon Rapids, Minnesota, United States, 55433
- Recruiting
- Mercy Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Deer River, Minnesota, United States, 56636
- Recruiting
- Essentia Health - Deer River Clinic
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Detroit Lakes, Minnesota, United States, 56501
- Recruiting
- Essentia Health Saint Mary's - Detroit Lakes Clinic
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Duluth, Minnesota, United States, 55805
- Recruiting
- Essentia Health Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Duluth, Minnesota, United States, 55805
- Recruiting
- Essentia Health Saint Mary's Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Duluth, Minnesota, United States, 55805
- Recruiting
- Miller-Dwan Hospital
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Edina, Minnesota, United States, 55435
- Recruiting
- Fairview Southdale Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Fergus Falls, Minnesota, United States, 56537
- Recruiting
- Lake Region Healthcare Corporation-Cancer Care
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Fosston, Minnesota, United States, 56542
- Recruiting
- Essentia Health - Fosston
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Fridley, Minnesota, United States, 55432
- Recruiting
- Unity Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Hibbing, Minnesota, United States, 55746
- Recruiting
- Essentia Health Hibbing Clinic
-
Principal Investigator:
- Bret E. Friday
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
-
Maple Grove, Minnesota, United States, 55369
- Recruiting
- Fairview Clinics and Surgery Center Maple Grove
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Maplewood, Minnesota, United States, 55109
- Recruiting
- Minnesota Oncology Hematology PA-Maplewood
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Maplewood, Minnesota, United States, 55109
- Recruiting
- Saint John's Hospital - Healtheast
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Minneapolis, Minnesota, United States, 55407
- Recruiting
- Abbott-Northwestern Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Minneapolis, Minnesota, United States, 55415
- Recruiting
- Hennepin County Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Minneapolis, Minnesota, United States, 55454
- Recruiting
- Health Partners Inc
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Monticello, Minnesota, United States, 55362
- Recruiting
- Monticello Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
New Ulm, Minnesota, United States, 56073
- Suspended
- New Ulm Medical Center
-
Park Rapids, Minnesota, United States, 56470
- Recruiting
- Essentia Health - Park Rapids
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Princeton, Minnesota, United States, 55371
- Suspended
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, United States, 55422
- Recruiting
- North Memorial Medical Health Center
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Principal Investigator:
- Taxiarchis Kourelis
-
Contact:
- Site Public Contact
- Phone Number: 855-776-0015
-
Saint Louis Park, Minnesota, United States, 55416
- Recruiting
- Park Nicollet Clinic - Saint Louis Park
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Saint Paul, Minnesota, United States, 55101
- Recruiting
- Regions Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Saint Paul, Minnesota, United States, 55102
- Recruiting
- United Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Sandstone, Minnesota, United States, 55072
- Recruiting
- Essentia Health Sandstone
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Shakopee, Minnesota, United States, 55379
- Recruiting
- Saint Francis Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Stillwater, Minnesota, United States, 55082
- Recruiting
- Lakeview Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Virginia, Minnesota, United States, 55792
- Recruiting
- Essentia Health Virginia Clinic
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Waconia, Minnesota, United States, 55387
- Recruiting
- Ridgeview Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Willmar, Minnesota, United States, 56201
- Recruiting
- Rice Memorial Hospital
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Woodbury, Minnesota, United States, 55125
- Recruiting
- Minnesota Oncology Hematology PA-Woodbury
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Wyoming, Minnesota, United States, 55092
- Suspended
- Fairview Lakes Medical Center
-
-
Missouri
-
Ballwin, Missouri, United States, 63011
- Recruiting
- Saint Louis Cancer and Breast Institute-Ballwin
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 314-251-7058
-
Bolivar, Missouri, United States, 65613
- Recruiting
- Central Care Cancer Center - Bolivar
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 913-948-5588
- Email: aroland@kccop.org
-
Branson, Missouri, United States, 65616
- Suspended
- Cox Cancer Center Branson
-
Creve Coeur, Missouri, United States, 63141
- Recruiting
- Siteman Cancer Center at West County Hospital
-
Principal Investigator:
- Keith E. Stockerl-Goldstein
-
Contact:
- Site Public Contact
- Phone Number: 800-600-3606
- Email: info@siteman.wustl.edu
-
Joplin, Missouri, United States, 64804
- Recruiting
- Freeman Health System
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 417-347-4030
- Email: LJCrockett@freemanhealth.com
-
Joplin, Missouri, United States, 64804
- Recruiting
- Mercy Hospital Joplin
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 417-556-3074
- Email: esmeralda.carrillo@mercy.net
-
Kansas City, Missouri, United States, 64111
- Recruiting
- Saint Luke's Hospital of Kansas City
-
Principal Investigator:
- Shahzad Raza
-
Contact:
- Site Public Contact
- Phone Number: 913-948-5588
- Email: aroland@kccop.org
-
Lee's Summit, Missouri, United States, 64086
- Recruiting
- Saint Luke's East - Lee's Summit
-
Principal Investigator:
- Shahzad Raza
-
Contact:
- Site Public Contact
- Phone Number: 913-948-5588
- Email: aroland@kccop.org
-
Rolla, Missouri, United States, 65401
- Recruiting
- Delbert Day Cancer Institute at PCRMC
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 573-458-7504
- Email: research@phelpshealth.org
-
Rolla, Missouri, United States, 65401
- Recruiting
- Mercy Clinic-Rolla-Cancer and Hematology
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 573-458-6379
-
Saint Joseph, Missouri, United States, 64506
- Recruiting
- Heartland Regional Medical Center
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 816-271-7937
- Email: linda.schumacher@mymlc.com
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Principal Investigator:
- Keith E. Stockerl-Goldstein
-
Contact:
- Site Public Contact
- Phone Number: 800-600-3606
- Email: info@siteman.wustl.edu
-
Saint Louis, Missouri, United States, 63141
- Recruiting
- Mercy Hospital Saint Louis
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 314-251-7066
-
Saint Louis, Missouri, United States, 63109
- Suspended
- Saint Louis Cancer and Breast Institute-South City
-
Saint Louis, Missouri, United States, 63129
- Recruiting
- Siteman Cancer Center-South County
-
Principal Investigator:
- Keith E. Stockerl-Goldstein
-
Contact:
- Site Public Contact
- Phone Number: 800-600-3606
- Email: info@siteman.wustl.edu
-
Saint Louis, Missouri, United States, 63136
- Recruiting
- Siteman Cancer Center at Christian Hospital
-
Principal Investigator:
- Keith E. Stockerl-Goldstein
-
Contact:
- Site Public Contact
- Phone Number: 800-600-3606
- Email: info@siteman.wustl.edu
-
Saint Louis, Missouri, United States, 63128
- Recruiting
- Mercy Hospital South
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Email: janet.lesko@mercy.net
-
Saint Peters, Missouri, United States, 63376
- Recruiting
- Siteman Cancer Center at Saint Peters Hospital
-
Principal Investigator:
- Keith E. Stockerl-Goldstein
-
Contact:
- Site Public Contact
- Phone Number: 800-600-3606
- Email: info@siteman.wustl.edu
-
Springfield, Missouri, United States, 65804
- Recruiting
- Mercy Hospital Springfield
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 417-269-4520
-
Springfield, Missouri, United States, 65807
- Recruiting
- CoxHealth South Hospital
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 417-269-4520
-
Washington, Missouri, United States, 63090
- Suspended
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, United States, 59711
- Suspended
- Community Hospital of Anaconda
-
Billings, Montana, United States, 59101
- Recruiting
- Billings Clinic Cancer Center
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 800-996-2663
- Email: research@billingsclinic.org
-
Billings, Montana, United States, 59101
- Suspended
- Saint Vincent Healthcare
-
Billings, Montana, United States, 59102
- Suspended
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, United States, 59715
- Recruiting
- Bozeman Deaconess Hospital
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Butte, Montana, United States, 59701
- Suspended
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, United States, 59405
- Recruiting
- Benefis Healthcare- Sletten Cancer Institute
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Great Falls, Montana, United States, 59405
- Recruiting
- Great Falls Clinic
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Kalispell, Montana, United States, 59901
- Recruiting
- Kalispell Regional Medical Center
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
Missoula, Montana, United States, 59802
- Suspended
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, United States, 59804
- Recruiting
- Community Medical Hospital
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
-
Nebraska
-
Grand Island, Nebraska, United States, 68803
- Recruiting
- CHI Health Saint Francis
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 855-313-2409
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Kearney, Nebraska, United States, 68847
- Recruiting
- CHI Health Good Samaritan
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 308-865-7963
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Lincoln, Nebraska, United States, 68510
- Suspended
- Saint Elizabeth Regional Medical Center
-
Omaha, Nebraska, United States, 68122
- Recruiting
- Alegent Health Immanuel Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 402-717-1510
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Omaha, Nebraska, United States, 68124
- Recruiting
- Alegent Health Bergan Mercy Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 402-717-1510
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Omaha, Nebraska, United States, 68130
- Recruiting
- Alegent Health Lakeside Hospital
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 402-717-1510
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Omaha, Nebraska, United States, 68131
- Recruiting
- Creighton University Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 402-717-1510
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Omaha, Nebraska, United States, 68198
- Active, not recruiting
- University of Nebraska Medical Center
-
Omaha, Nebraska, United States, 68118
- Active, not recruiting
- Nebraska Medicine-Village Pointe
-
Papillion, Nebraska, United States, 68046
- Suspended
- Midlands Community Hospital
-
-
Nevada
-
Carson City, Nevada, United States, 89703
- Suspended
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, United States, 89052
- Recruiting
- Comprehensive Cancer Centers of Nevada - Henderson
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Henderson, Nevada, United States, 89052
- Recruiting
- OptumCare Cancer Care at Seven Hills
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Henderson, Nevada, United States, 89052
- Suspended
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, United States, 89052
- Suspended
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, United States, 89052
- Suspended
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, United States, 89074
- Suspended
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, United States, 89074
- Suspended
- Las Vegas Urology - Green Valley
-
Henderson, Nevada, United States, 89074
- Suspended
- Las Vegas Urology - Pebble
-
Henderson, Nevada, United States, 89074
- Suspended
- Urology Specialists of Nevada - Green Valley
-
Henderson, Nevada, United States, 89074
- Suspended
- 21st Century Oncology-Henderson
-
Las Vegas, Nevada, United States, 89102
- Suspended
- Desert West Surgery
-
Las Vegas, Nevada, United States, 89102
- Recruiting
- OptumCare Cancer Care at Charleston
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89106
- Suspended
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, United States, 89106
- Recruiting
- Radiation Oncology Centers of Nevada Central
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89109
- Suspended
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, United States, 89113
- Suspended
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, United States, 89119
- Recruiting
- Radiation Oncology Centers of Nevada Southeast
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89128
- Suspended
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, United States, 89128
- Recruiting
- Comprehensive Cancer Centers of Nevada - Northwest
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89128
- Suspended
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, United States, 89128
- Recruiting
- OptumCare Cancer Care at MountainView
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89135
- Recruiting
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89144
- Recruiting
- Comprehensive Cancer Centers of Nevada - Town Center
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89144
- Recruiting
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89148
- Recruiting
- Comprehensive Cancer Centers of Nevada
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89148
- Recruiting
- OptumCare Cancer Care at Fort Apache
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89149
- Suspended
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, United States, 89169
- Recruiting
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89074
- Suspended
- Las Vegas Urology - Pecos
-
Las Vegas, Nevada, United States, 89102
- Suspended
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, United States, 89103
- Suspended
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, United States, 89106
- Suspended
- Urology Specialists of Nevada - Central
-
Las Vegas, Nevada, United States, 89109
- Suspended
- Sunrise Hospital and Medical Center
-
Las Vegas, Nevada, United States, 89113
- Suspended
- Las Vegas Prostate Cancer Center
-
Las Vegas, Nevada, United States, 89113
- Suspended
- Las Vegas Urology - Sunset
-
Las Vegas, Nevada, United States, 89113
- Suspended
- Urology Specialists of Nevada - Southwest
-
Las Vegas, Nevada, United States, 89128
- Suspended
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, United States, 89128
- Suspended
- Las Vegas Urology - Cathedral Rock
-
Las Vegas, Nevada, United States, 89128
- Suspended
- Las Vegas Urology - Smoke Ranch
-
Las Vegas, Nevada, United States, 89128
- Suspended
- Urology Specialists of Nevada - Northwest
-
Las Vegas, Nevada, United States, 89144
- Suspended
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, United States, 89148-2405
- Suspended
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, United States, 89169
- Suspended
- University Cancer Center
-
Las Vegas, Nevada, United States, 89109
- Recruiting
- 21st Century Oncology
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Las Vegas, Nevada, United States, 89128
- Suspended
- 21st Century Oncology-Vegas Tenaya
-
Las Vegas, Nevada, United States, 89148
- Suspended
- 21st Century Oncology-Fort Apache
-
Pahrump, Nevada, United States, 89048
- Suspended
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, United States, 89502
- Recruiting
- Renown Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Reno, Nevada, United States, 89503
- Recruiting
- Saint Mary's Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
Reno, Nevada, United States, 89509
- Recruiting
- Radiation Oncology Associates
-
Contact:
- Site Public Contact
- Phone Number: 702-384-0013
- Email: research@sncrf.org
-
Principal Investigator:
- John A. Ellerton
-
-
New Jersey
-
Morristown, New Jersey, United States, 07960
- Recruiting
- Morristown Medical Center
-
Principal Investigator:
- Mohamad A. Cherry
-
Contact:
- Site Public Contact
- Phone Number: 973-971-5900
-
-
New York
-
Glens Falls, New York, United States, 12801
- Recruiting
- Glens Falls Hospital
-
Contact:
- Site Public Contact
- Phone Number: 518-926-6700
-
Principal Investigator:
- Christopher R. Mason
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- UNC Lineberger Comprehensive Cancer Center
-
Principal Investigator:
- Sascha A. Tuchman
-
Contact:
- Site Public Contact
- Phone Number: 877-668-0683
- Email: cancerclinicaltrials@med.unc.edu
-
Charlotte, North Carolina, United States, 28203
- Recruiting
- Carolinas Medical Center/Levine Cancer Institute
-
Principal Investigator:
- Manisha Bhutani
-
Contact:
- Site Public Contact
- Phone Number: 800-804-9376
-
Kenansville, North Carolina, United States, 28349
- Recruiting
- Vidant Oncology-Kenansville
-
Principal Investigator:
- Misbah U. Qadir
-
Contact:
- Site Public Contact
- Phone Number: 252-559-2201
- Email: Carla.Zimmerman@vidanthealth.com
-
Kinston, North Carolina, United States, 28501
- Recruiting
- Vidant Oncology-Kinston
-
Principal Investigator:
- Misbah U. Qadir
-
Contact:
- Site Public Contact
- Phone Number: 252-559-2201
- Email: Carla.Zimmerman@vidanthealth.com
-
Richlands, North Carolina, United States, 28574
- Recruiting
- Vidant Oncology-Richlands
-
Principal Investigator:
- Misbah U. Qadir
-
Contact:
- Site Public Contact
- Phone Number: 252-559-2201
- Email: Carla.Zimmerman@vidanthealth.com
-
-
North Dakota
-
Fargo, North Dakota, United States, 58103
- Recruiting
- Essentia Health Cancer Center-South University Clinic
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Jamestown, North Dakota, United States, 58401
- Recruiting
- Essentia Health - Jamestown Clinic
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
-
Ohio
-
Beavercreek, Ohio, United States, 45431
- Recruiting
- Indu and Raj Soin Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Belpre, Ohio, United States, 45714
- Suspended
- Strecker Cancer Center-Belpre
-
Boardman, Ohio, United States, 44512
- Recruiting
- Saint Elizabeth Boardman Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Centerville, Ohio, United States, 45459
- Recruiting
- Dayton Physicians LLC-Miami Valley South
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Centerville, Ohio, United States, 45459
- Recruiting
- Miami Valley Hospital South
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Chardon, Ohio, United States, 44024
- Recruiting
- Geauga Hospital
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Chillicothe, Ohio, United States, 45601
- Recruiting
- Adena Regional Medical Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 877-779-7585
- Email: sheree@columbusccop.org
-
Cincinnati, Ohio, United States, 45236
- Recruiting
- Oncology Hematology Care Inc-Kenwood
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Cincinnati, Ohio, United States, 45247
- Suspended
- TriHealth Cancer Institute-Westside
-
Cincinnati, Ohio, United States, 45255
- Suspended
- TriHealth Cancer Institute-Anderson
-
Cincinnati, Ohio, United States, 45220
- Recruiting
- Good Samaritan Hospital - Cincinnati
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 513-853-1300
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Cincinnati, Ohio, United States, 45242
- Recruiting
- Bethesda North Hospital
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 513-853-1300
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic Foundation
-
Principal Investigator:
- Jack Khouri
-
Contact:
- Site Public Contact
- Phone Number: 866-223-8100
- Email: TaussigResearch@ccf.org
-
Cleveland, Ohio, United States, 44106
- Recruiting
- Case Western Reserve University
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Cleveland, Ohio, United States, 44109
- Recruiting
- MetroHealth Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 216-778-8526
- Email: dstrater@metrohealth.org
-
Principal Investigator:
- William Tse
-
Columbus, Ohio, United States, 43213
- Recruiting
- Mount Carmel East Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43214
- Recruiting
- Riverside Methodist Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-566-4475
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43215
- Recruiting
- Grant Medical Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-566-4475
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43219
- Recruiting
- The Mark H Zangmeister Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43222
- Recruiting
- Mount Carmel Health Center West
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-234-5433
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43228
- Recruiting
- Doctors Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-566-3275
- Email: sheree@columbusccop.org
-
Columbus, Ohio, United States, 43214
- Suspended
- Columbus Oncology and Hematology Associates Inc
-
Dayton, Ohio, United States, 45406
- Suspended
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, United States, 45409
- Recruiting
- Miami Valley Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Dayton, Ohio, United States, 45415
- Recruiting
- Dayton Physician LLC-Miami Valley Hospital North
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Dayton, Ohio, United States, 45415
- Recruiting
- Miami Valley Hospital North
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Dayton, Ohio, United States, 45428
- Recruiting
- Dayton Veterans Affairs Medical Center
-
Principal Investigator:
- Albert S. Malcolm
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Delaware, Ohio, United States, 43015
- Recruiting
- Delaware Health Center-Grady Cancer Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 740-615-0227
- Email: sheree@columbusccop.org
-
Delaware, Ohio, United States, 43015
- Suspended
- Grady Memorial Hospital
-
Dublin, Ohio, United States, 43016
- Recruiting
- Dublin Methodist Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 800-752-9119
- Email: sheree@columbusccop.org
-
Findlay, Ohio, United States, 45840
- Recruiting
- Armes Family Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Findlay, Ohio, United States, 45840
- Recruiting
- Blanchard Valley Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Findlay, Ohio, United States, 45840
- Recruiting
- Orion Cancer Care
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Franklin, Ohio, United States, 45005-1066
- Recruiting
- Atrium Medical Center-Middletown Regional Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Franklin, Ohio, United States, 45005
- Recruiting
- Dayton Physicians LLC-Atrium
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Gahanna, Ohio, United States, 43230
- Suspended
- Central Ohio Breast and Endocrine Surgery
-
Greenville, Ohio, United States, 45331
- Recruiting
- Dayton Physicians LLC-Wayne
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Greenville, Ohio, United States, 45331
- Recruiting
- Wayne Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Grove City, Ohio, United States, 43123
- Recruiting
- Mount Carmel Grove City Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 877-779-7585
- Email: sheree@columbusccop.org
-
Kettering, Ohio, United States, 45409
- Recruiting
- Greater Dayton Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Kettering, Ohio, United States, 45429
- Recruiting
- Kettering Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Kettering, Ohio, United States, 45420
- Suspended
- First Dayton Cancer Care
-
Lancaster, Ohio, United States, 43130
- Suspended
- Fairfield Medical Center
-
Lima, Ohio, United States, 45801
- Recruiting
- Saint Rita's Medical Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 419-226-9617
-
Mansfield, Ohio, United States, 44903
- Recruiting
- OhioHealth Mansfield Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 419-526-8018
- Email: sheree@columbusccop.org
-
Marietta, Ohio, United States, 45750
- Recruiting
- Marietta Memorial Hospital
-
Contact:
- Site Public Contact
- Phone Number: 800-523-3977
- Email: sheree@columbusccop.org
-
Principal Investigator:
- Timothy D. Moore
-
Marion, Ohio, United States, 43302
- Suspended
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, United States, 44124
- Recruiting
- UH Seidman Cancer Center at Landerbrook Health Center
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Mentor, Ohio, United States, 44060
- Recruiting
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Middleburg Heights, Ohio, United States, 44130
- Recruiting
- UH Seidman Cancer Center at Southwest General Hospital
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Mount Vernon, Ohio, United States, 43050
- Suspended
- Knox Community Hospital
-
Newark, Ohio, United States, 43055
- Recruiting
- Licking Memorial Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 740-348-4000
- Email: sheree@columbusccop.org
-
Newark, Ohio, United States, 43055
- Recruiting
- Newark Radiation Oncology
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Perrysburg, Ohio, United States, 43551
- Recruiting
- Mercy Health Perrysburg Cancer Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Portsmouth, Ohio, United States, 45662
- Recruiting
- Southern Ohio Medical Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Sandusky, Ohio, United States, 44870
- Recruiting
- UH Seidman Cancer Center at Firelands Regional Medical Center
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Springfield, Ohio, United States, 45504
- Recruiting
- Springfield Regional Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Springfield, Ohio, United States, 45505
- Recruiting
- Springfield Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Toledo, Ohio, United States, 43608
- Recruiting
- Saint Vincent Mercy Medical Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Toledo, Ohio, United States, 43623
- Recruiting
- Mercy Health - Saint Anne Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-488-2118
- Email: sheree@columbusccop.org
-
Toledo, Ohio, United States, 43623
- Recruiting
- Toledo Clinic Cancer Centers-Toledo
-
Principal Investigator:
- Rex B. Mowat
-
Contact:
- Site Public Contact
- Phone Number: 800-444-3561
-
Troy, Ohio, United States, 45373
- Recruiting
- Dayton Physicians LLC-Upper Valley
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Troy, Ohio, United States, 45373
- Recruiting
- Upper Valley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Warren, Ohio, United States, 44484
- Recruiting
- Saint Joseph Warren Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Westerville, Ohio, United States, 43081
- Recruiting
- Saint Ann's Hospital
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 614-234-5433
- Email: sheree@columbusccop.org
-
Westlake, Ohio, United States, 44145
- Recruiting
- UH Seidman Cancer Center at Saint John Medical Center
-
Principal Investigator:
- Brenda W. Cooper
-
Contact:
- Site Public Contact
- Phone Number: 800-641-2422
- Email: CTUReferral@UHhospitals.org
-
Youngstown, Ohio, United States, 44501
- Recruiting
- Saint Elizabeth Youngstown Hospital
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Zanesville, Ohio, United States, 43701
- Recruiting
- Genesis Healthcare System Cancer Care Center
-
Principal Investigator:
- Timothy D. Moore
-
Contact:
- Site Public Contact
- Phone Number: 740-454-5232
- Email: sheree@columbusccop.org
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Recruiting
- Mercy Hospital Oklahoma City
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 405-752-3402
-
-
Oregon
-
Baker City, Oregon, United States, 97814
- Suspended
- Saint Alphonsus Medical Center-Baker City
-
Bend, Oregon, United States, 97701
- Recruiting
- Saint Charles Health System
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 541-706-2909
- Email: nosall@stcharleshealthcare.org
-
Clackamas, Oregon, United States, 97015
- Recruiting
- Providence Cancer Institute Clackamas Clinic
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Clackamas, Oregon, United States, 97015
- Recruiting
- Clackamas Radiation Oncology Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Coos Bay, Oregon, United States, 97420
- Recruiting
- Bay Area Hospital
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 541-269-8392
- Email: cherie.cox@bayareahospital.org
-
Newberg, Oregon, United States, 97132
- Recruiting
- Providence Newberg Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Ontario, Oregon, United States, 97914
- Suspended
- Saint Alphonsus Medical Center-Ontario
-
Portland, Oregon, United States, 97239
- Recruiting
- Oregon Health and Science University
-
Principal Investigator:
- Eva Medvedova
-
Contact:
- Site Public Contact
- Phone Number: 503-494-1080
- Email: trials@ohsu.edu
-
Portland, Oregon, United States, 97213
- Recruiting
- Providence Portland Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Portland, Oregon, United States, 97225
- Recruiting
- Providence Saint Vincent Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Redmond, Oregon, United States, 97756
- Suspended
- Saint Charles Health System-Redmond
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18103
- Recruiting
- Lehigh Valley Hospital-Cedar Crest
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Bethlehem, Pennsylvania, United States, 18017
- Recruiting
- Lehigh Valley Hospital - Muhlenberg
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Danville, Pennsylvania, United States, 17822
- Recruiting
- Geisinger Medical Center
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-271-5251
- Email: HemonCCTrials@geisinger.edu
-
East Stroudsburg, Pennsylvania, United States, 18301
- Recruiting
- Pocono Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 734-712-3671
- Email: stephanie.couch@stjoeshealth.org
-
Principal Investigator:
- Christopher M. Reynolds
-
Hazleton, Pennsylvania, United States, 18201
- Recruiting
- Geisinger Medical Center-Cancer Center Hazleton
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-459-2901
- Email: HemonCCTrials@geisinger.edu
-
Hazleton, Pennsylvania, United States, 18201
- Suspended
- Lehigh Valley Hospital-Hazleton
-
Lewisburg, Pennsylvania, United States, 17837
- Recruiting
- Geisinger Medical Oncology-Lewisburg
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-374-8555
- Email: HemonCCTrials@geisinger.edu
-
Lewistown, Pennsylvania, United States, 17044
- Recruiting
- Lewistown Hospital
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 717-242-7703
- Email: HemonCCTrials@geisinger.edu
-
Philadelphia, Pennsylvania, United States, 19107
- Active, not recruiting
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, United States, 15224
- Recruiting
- West Penn Hospital
-
Principal Investigator:
- Prerna Mewawalla
-
Contact:
- Site Public Contact
- Phone Number: 412-578-5000
-
Pittsburgh, Pennsylvania, United States, 15212
- Recruiting
- Allegheny General Hospital
-
Principal Investigator:
- Prerna Mewawalla
-
Contact:
- Site Public Contact
- Phone Number: 877-284-2000
-
Pottstown, Pennsylvania, United States, 19464
- Recruiting
- Pottstown Hospital
-
Contact:
- Site Public Contact
- Phone Number: 610-327-7544
-
Principal Investigator:
- Jeffrey A. Stevens
-
Pottsville, Pennsylvania, United States, 17901
- Recruiting
- Geisinger Cancer Services-Pottsville
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 800-275-6401
- Email: HemonCCTrials@geisinger.edu
-
Scranton, Pennsylvania, United States, 18510
- Recruiting
- Community Medical Center
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-703-4768
- Email: HemonCCTrials@geisinger.edu
-
Selinsgrove, Pennsylvania, United States, 17870
- Recruiting
- Geisinger Medical Oncology-Selinsgrove
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-374-8555
- Email: HemonCCTrials@geisinger.edu
-
State College, Pennsylvania, United States, 16801
- Suspended
- Geisinger Medical Group
-
West Reading, Pennsylvania, United States, 19611
- Recruiting
- Reading Hospital
-
Contact:
- Site Public Contact
- Phone Number: 610-988-9323
-
Principal Investigator:
- Terrence P. Cescon
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Recruiting
- Geisinger Wyoming Valley/Henry Cancer Center
-
Principal Investigator:
- Parth R. Rao
-
Contact:
- Site Public Contact
- Phone Number: 570-271-5251
- Email: HemonCCTrials@geisinger.edu
-
-
Rhode Island
-
Westerly, Rhode Island, United States, 02891
- Recruiting
- Smilow Cancer Hospital Care Center - Westerly
-
Principal Investigator:
- Noffar Bar
-
Contact:
- Site Public Contact
- Phone Number: 203-785-5702
- Email: canceranswers@yale.edu
-
-
South Carolina
-
Boiling Springs, South Carolina, United States, 29316
- Suspended
- Prisma Health Cancer Institute - Spartanburg
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Principal Investigator:
- Amarendra K. Neppalli
-
Contact:
- Site Public Contact
- Phone Number: 843-792-9321
- Email: hcc-clinical-trials@musc.edu
-
Easley, South Carolina, United States, 29640
- Suspended
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, United States, 29605
- Recruiting
- Prisma Health Cancer Institute - Faris
-
Contact:
- Site Public Contact
- Phone Number: 864-241-6251
-
Principal Investigator:
- Ki Y. Chung
-
Greenville, South Carolina, United States, 29615
- Recruiting
- Prisma Health Cancer Institute - Eastside
-
Contact:
- Site Public Contact
- Phone Number: 864-241-6251
-
Principal Investigator:
- Ki Y. Chung
-
Greenville, South Carolina, United States, 29605
- Recruiting
- Prisma Health Greenville Memorial Hospital
-
Contact:
- Site Public Contact
- Phone Number: 864-241-6251
-
Principal Investigator:
- Ki Y. Chung
-
Greenville, South Carolina, United States, 29605
- Suspended
- Prisma Health Cancer Institute - Butternut
-
Greenwood, South Carolina, United States, 29646
- Active, not recruiting
- Self Regional Healthcare
-
Greer, South Carolina, United States, 29650
- Recruiting
- Prisma Health Cancer Institute - Greer
-
Contact:
- Site Public Contact
- Phone Number: 864-241-6251
-
Principal Investigator:
- Ki Y. Chung
-
Seneca, South Carolina, United States, 29672
- Recruiting
- Prisma Health Cancer Institute - Seneca
-
Contact:
- Site Public Contact
- Phone Number: 864-241-6251
-
Principal Investigator:
- Ki Y. Chung
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Active, not recruiting
- Avera Cancer Institute
-
-
Texas
-
Bryan, Texas, United States, 77802
- Recruiting
- Saint Joseph Regional Cancer Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 855-313-2409
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Dallas, Texas, United States, 75390
- Recruiting
- UT Southwestern/Simmons Cancer Center-Dallas
-
Principal Investigator:
- Ankit Kansagra
-
Contact:
- Site Public Contact
- Phone Number: 214-648-7097
- Email: canceranswerline@UTSouthwestern.edu
-
Fort Worth, Texas, United States, 76104
- Recruiting
- UT Southwestern/Simmons Cancer Center-Fort Worth
-
Principal Investigator:
- Ankit Kansagra
-
Contact:
- Site Public Contact
- Phone Number: 214-648-7097
- Email: canceranswerline@UTSouthwestern.edu
-
Houston, Texas, United States, 77030
- Recruiting
- M D Anderson Cancer Center
-
Principal Investigator:
- Elisabet E. Manasanch
-
Contact:
- Site Public Contact
- Phone Number: 877-632-6789
- Email: askmdanderson@mdanderson.org
-
Richardson, Texas, United States, 75080
- Recruiting
- UT Southwestern Clinical Center at Richardson/Plano
-
Principal Investigator:
- Ankit Kansagra
-
Contact:
- Site Public Contact
- Phone Number: 972-669-7044
- Email: Suzanne.cole@utsouthwestern.edu
-
-
Utah
-
American Fork, Utah, United States, 84003
- Suspended
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, United States, 84720
- Suspended
- Sandra L Maxwell Cancer Center
-
Logan, Utah, United States, 84321
- Suspended
- Logan Regional Hospital
-
Murray, Utah, United States, 84107
- Suspended
- Intermountain Medical Center
-
Ogden, Utah, United States, 84403
- Suspended
- McKay-Dee Hospital Center
-
Provo, Utah, United States, 84604
- Suspended
- Utah Valley Regional Medical Center
-
Riverton, Utah, United States, 84065
- Suspended
- Riverton Hospital
-
Saint George, Utah, United States, 84770
- Suspended
- Dixie Medical Center Regional Cancer Center
-
Salt Lake City, Utah, United States, 84112
- Recruiting
- Huntsman Cancer Institute/University of Utah
-
Principal Investigator:
- Douglas W. Sborov
-
Contact:
- Site Public Contact
- Phone Number: 888-424-2100
- Email: cancerinfo@hci.utah.edu
-
Salt Lake City, Utah, United States, 84106
- Suspended
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, United States, 84143
- Suspended
- LDS Hospital
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- Recruiting
- University of Virginia Cancer Center
-
Principal Investigator:
- Laahn H. Foster
-
Contact:
- Site Public Contact
- Phone Number: 434-243-6303
- Email: uvacancertrials@hscmail.mcc.virginia.edu
-
-
Washington
-
Aberdeen, Washington, United States, 98520
- Recruiting
- Providence Regional Cancer System-Aberdeen
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-412-8958
- Email: deidre.dillon@providence.org
-
Auburn, Washington, United States, 98001
- Suspended
- MultiCare Auburn Medical Center
-
Bellevue, Washington, United States, 98004
- Recruiting
- Overlake Medical Center
-
Principal Investigator:
- John A. Ellerton
-
Contact:
- Site Public Contact
- Phone Number: 425-688-5407
- Email: OHMCResearch@overlakehospital.org
-
Bellingham, Washington, United States, 98225
- Recruiting
- PeaceHealth Saint Joseph Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-788-8238
- Email: lkey@peacehealth.org
-
Bremerton, Washington, United States, 98310
- Recruiting
- Harrison HealthPartners Hematology and Oncology-Bremerton
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 308-398-6518
- Email: clinicaltrials@sfmc-gi.org
-
Bremerton, Washington, United States, 98310
- Recruiting
- Harrison Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 253-426-6882
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Burien, Washington, United States, 98166
- Recruiting
- Highline Medical Center-Main Campus
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 253-426-6882
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Centralia, Washington, United States, 98531
- Recruiting
- Providence Regional Cancer System-Centralia
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-412-8958
- Email: deidre.dillon@providence.org
-
Edmonds, Washington, United States, 98026
- Recruiting
- Swedish Cancer Institute-Edmonds
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Enumclaw, Washington, United States, 98022
- Suspended
- Saint Elizabeth Hospital
-
Everett, Washington, United States, 98201
- Recruiting
- Providence Regional Cancer Partnership
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 425-261-3529
- Email: marilyn.birchman@providence.org
-
Federal Way, Washington, United States, 98003
- Suspended
- Saint Francis Hospital
-
Gig Harbor, Washington, United States, 98335
- Suspended
- MultiCare Gig Harbor Medical Park
-
Issaquah, Washington, United States, 98029
- Recruiting
- Swedish Cancer Institute-Issaquah
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Kennewick, Washington, United States, 99336
- Suspended
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, United States, 98503
- Recruiting
- Providence Regional Cancer System-Lacey
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-412-8958
- Email: deidre.dillon@providence.org
-
Lakewood, Washington, United States, 98499
- Suspended
- Saint Clare Hospital
-
Longview, Washington, United States, 98632
- Recruiting
- PeaceHealth Saint John Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-514-2016
- Email: kmakin-bond@peacehealth.org
-
Port Townsend, Washington, United States, 98368
- Suspended
- Jefferson Healthcare
-
Poulsbo, Washington, United States, 98370
- Suspended
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Puyallup, Washington, United States, 98372
- Suspended
- MultiCare Good Samaritan Hospital
-
Renton, Washington, United States, 98055
- Recruiting
- Valley Medical Center
-
Principal Investigator:
- John A. Ellerton
-
Contact:
- Site Public Contact
- Phone Number: 425-228-3440
- Email: research@valleymed.org
-
Seattle, Washington, United States, 98104
- Suspended
- Pacific Gynecology Specialists
-
Seattle, Washington, United States, 98122-5711
- Suspended
- Swedish Medical Center-Cherry Hill
-
Seattle, Washington, United States, 98107
- Recruiting
- Swedish Medical Center-Ballard Campus
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Seattle, Washington, United States, 98109
- Recruiting
- Fred Hutchinson Cancer Research Center
-
Principal Investigator:
- Andrew J. Cowan
-
Contact:
- Site Public Contact
- Phone Number: 800-804-8824
-
Seattle, Washington, United States, 98195
- Recruiting
- University of Washington Medical Center - Montlake
-
Principal Investigator:
- Andrew J. Cowan
-
Contact:
- Site Public Contact
- Phone Number: 800-804-8824
-
Seattle, Washington, United States, 98109
- Recruiting
- Seattle Cancer Care Alliance
-
Principal Investigator:
- Andrew J. Cowan
-
Contact:
- Site Public Contact
- Phone Number: 800-804-8824
-
Seattle, Washington, United States, 98122-4307
- Recruiting
- Swedish Medical Center-First Hill
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Seattle, Washington, United States, 98133
- Recruiting
- Seattle Cancer Care Alliance at Northwest Hospital
-
Contact:
- Site Public Contact
- Phone Number: 206-606-5800
-
Principal Investigator:
- Paul S. Martin
-
Sedro-Woolley, Washington, United States, 98284
- Recruiting
- PeaceHealth United General Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-788-8238
- Email: lkey@peacehealth.org
-
Shelton, Washington, United States, 98584
- Suspended
- Providence Regional Cancer System-Shelton
-
Spokane, Washington, United States, 99204
- Suspended
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, United States, 99218
- Suspended
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
Spokane Valley, Washington, United States, 99216
- Suspended
- MultiCare Deaconess Cancer and Blood Specialty Center - Valley
-
Tacoma, Washington, United States, 98405
- Suspended
- Franciscan Research Center-Northwest Medical Plaza
-
Tacoma, Washington, United States, 98405
- Suspended
- MultiCare Tacoma General Hospital
-
Tacoma, Washington, United States, 98405
- Suspended
- Mary Bridge Children's Hospital and Health Center
-
Vancouver, Washington, United States, 98664
- Recruiting
- PeaceHealth Southwest Medical Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 360-514-3940
- Email: kmakin-bond@peacehealth.org
-
Walla Walla, Washington, United States, 99362
- Recruiting
- Providence Saint Mary Regional Cancer Center
-
Principal Investigator:
- Alison K. Conlin
-
Contact:
- Site Public Contact
- Phone Number: 509-897-5993
- Email: Cheryl.Dodd@providence.org
-
Yakima, Washington, United States, 98902
- Recruiting
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Principal Investigator:
- John A. Ellerton
-
Contact:
- Site Public Contact
- Phone Number: 509-574-3535
- Email: Memorial-ClinicalTrials@yvmh.org
-
Yelm, Washington, United States, 98597
- Suspended
- Providence Regional Cancer System-Yelm
-
-
West Virginia
-
Bridgeport, West Virginia, United States, 26330
- Suspended
- United Hospital Center
-
Charleston, West Virginia, United States, 25304
- Recruiting
- West Virginia University Charleston Division
-
Contact:
- Site Public Contact
- Phone Number: 304-388-9944
-
Principal Investigator:
- Steven J. Jubelirer
-
Martinsburg, West Virginia, United States, 25401
- Suspended
- WVUH-Berkely Medical Center
-
Morgantown, West Virginia, United States, 26506
- Recruiting
- West Virginia University Healthcare
-
Contact:
- Site Public Contact
- Phone Number: 304-293-7374
- Email: cancertrialsinfo@hsc.wvu.edu
-
Principal Investigator:
- Lauren W. Veltri
-
Parkersburg, West Virginia, United States, 26101
- Suspended
- Camden Clark Medical Center
-
-
Wisconsin
-
Appleton, Wisconsin, United States, 54911
- Recruiting
- ThedaCare Regional Cancer Center
-
Principal Investigator:
- Natasha C. Edwin
-
Contact:
- Site Public Contact
- Phone Number: 920-364-3605
- Email: ResearchDept@thedacare.org
-
Ashland, Wisconsin, United States, 54806
- Recruiting
- Duluth Clinic Ashland
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Ashland, Wisconsin, United States, 54806
- Recruiting
- Northwest Wisconsin Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 218-786-3308
- Email: CancerTrials@EssentiaHealth.org
-
Principal Investigator:
- Bret E. Friday
-
Burlington, Wisconsin, United States, 53105
- Recruiting
- Aurora Cancer Care-Southern Lakes VLCC
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Eau Claire, Wisconsin, United States, 54701
- Recruiting
- Marshfield Medical Center-EC Cancer Center
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
Eau Claire, Wisconsin, United States, 54701
- Recruiting
- Mayo Clinic Health System-Eau Claire Clinic
-
Principal Investigator:
- Taxiarchis Kourelis
-
Contact:
- Site Public Contact
- Phone Number: 855-776-0015
-
Fond Du Lac, Wisconsin, United States, 54937
- Recruiting
- Aurora Health Center-Fond du Lac
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Germantown, Wisconsin, United States, 53022
- Recruiting
- Aurora Health Care Germantown Health Center
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Grafton, Wisconsin, United States, 53024
- Recruiting
- Aurora Cancer Care-Grafton
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Green Bay, Wisconsin, United States, 54311
- Recruiting
- Aurora BayCare Medical Center
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Green Bay, Wisconsin, United States, 54301
- Recruiting
- Saint Vincent Hospital Cancer Center Green Bay
-
Contact:
- Site Public Contact
- Phone Number: 920-433-8889
- Email: ewd_research_admin@hshs.org
-
Principal Investigator:
- Brian L. Burnette
-
Green Bay, Wisconsin, United States, 54303
- Recruiting
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Contact:
- Site Public Contact
- Phone Number: 920-433-8889
- Email: ewd_research_admin@hshs.org
-
Principal Investigator:
- Brian L. Burnette
-
Kenosha, Wisconsin, United States, 53142
- Recruiting
- Aurora Cancer Care-Kenosha South
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
La Crosse, Wisconsin, United States, 54601
- Recruiting
- Gundersen Lutheran Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 608-775-2385
- Email: cancerctr@gundersenhealth.org
-
Principal Investigator:
- Kurt Oettel
-
Madison, Wisconsin, United States, 53792
- Recruiting
- University of Wisconsin Hospital and Clinics
-
Principal Investigator:
- Natalie S. Callander
-
Contact:
- Site Public Contact
- Phone Number: 800-622-8922
-
Marinette, Wisconsin, United States, 54143
- Recruiting
- Aurora Bay Area Medical Group-Marinette
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Marshfield, Wisconsin, United States, 54449
- Recruiting
- Marshfield Medical Center-Marshfield
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
Milwaukee, Wisconsin, United States, 53209
- Recruiting
- Aurora Cancer Care-Milwaukee
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Milwaukee, Wisconsin, United States, 53215
- Recruiting
- Aurora Saint Luke's Medical Center
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Milwaukee, Wisconsin, United States, 53233
- Recruiting
- Aurora Sinai Medical Center
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Minocqua, Wisconsin, United States, 54548
- Recruiting
- Marshfield Clinic-Minocqua Center
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
Mukwonago, Wisconsin, United States, 53149
- Recruiting
- ProHealth D N Greenwald Center
-
Contact:
- Site Public Contact
- Email: research.institute@phci.org
-
Principal Investigator:
- Timothy R. Wassenaar
-
New Richmond, Wisconsin, United States, 54017
- Recruiting
- Cancer Center of Western Wisconsin
-
Contact:
- Site Public Contact
- Phone Number: 952-993-1517
- Email: mmcorc@healthpartners.com
-
Principal Investigator:
- David M. King
-
Oconomowoc, Wisconsin, United States, 53066
- Recruiting
- ProHealth Oconomowoc Memorial Hospital
-
Principal Investigator:
- Timothy R. Wassenaar
-
Contact:
- Site Public Contact
- Phone Number: 262-928-7878
-
Oconto Falls, Wisconsin, United States, 54154
- Recruiting
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Contact:
- Site Public Contact
- Phone Number: 920-433-8889
- Email: ewd_research_admin@hshs.org
-
Principal Investigator:
- Brian L. Burnette
-
Oshkosh, Wisconsin, United States, 54904
- Recruiting
- Vince Lombardi Cancer Clinic - Oshkosh
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Racine, Wisconsin, United States, 53406
- Recruiting
- Aurora Cancer Care-Racine
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Rice Lake, Wisconsin, United States, 54868
- Recruiting
- Marshfield Medical Center-Rice Lake
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
Sheboygan, Wisconsin, United States, 53081
- Recruiting
- Vince Lombardi Cancer Clinic-Sheboygan
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Stevens Point, Wisconsin, United States, 54482
- Recruiting
- Marshfield Clinic Stevens Point Center
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
Sturgeon Bay, Wisconsin, United States, 54235-1495
- Recruiting
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Contact:
- Site Public Contact
- Phone Number: 920-433-8889
- Email: ewd_research_admin@hshs.org
-
Principal Investigator:
- Brian L. Burnette
-
Summit, Wisconsin, United States, 53066
- Recruiting
- Aurora Medical Center in Summit
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Two Rivers, Wisconsin, United States, 54241
- Recruiting
- Vince Lombardi Cancer Clinic-Two Rivers
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Waukesha, Wisconsin, United States, 53188
- Suspended
- ProHealth Waukesha Memorial Hospital
-
Waukesha, Wisconsin, United States, 53188
- Recruiting
- UW Cancer Center at ProHealth Care
-
Principal Investigator:
- Timothy R. Wassenaar
-
Contact:
- Site Public Contact
- Phone Number: 262-928-5539
- Email: Chanda.miller@phci.org
-
Wauwatosa, Wisconsin, United States, 53226
- Recruiting
- Aurora Cancer Care-Milwaukee West
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
West Allis, Wisconsin, United States, 53227
- Recruiting
- Aurora West Allis Medical Center
-
Principal Investigator:
- Michael A. Thompson
-
Contact:
- Site Public Contact
- Phone Number: 414-302-2304
- Email: ncorp@aurora.org
-
Weston, Wisconsin, United States, 54476
- Recruiting
- Marshfield Medical Center - Weston
-
Principal Investigator:
- Ali W. Bseiso
-
Contact:
- Site Public Contact
- Phone Number: 800-782-8581
- Email: oncology.clinical.trials@marshfieldresearch.org
-
-
Wyoming
-
Cheyenne, Wyoming, United States, 82001
- Suspended
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, United States, 82414
- Suspended
- Billings Clinic-Cody
-
Sheridan, Wyoming, United States, 82801
- Recruiting
- Welch Cancer Center
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 406-969-6060
- Email: mccinfo@mtcancer.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients must be diagnosed with asymptomatic high-risk smoldering multiple myeloma (SMM) within the past 12 months. High-risk is defined by the presence of 2 or more of the following factors:
- Abnormal serum free light chain ratio of involved to uninvolved >20, but less than 100 if the involved FLC is >= 10 mg/dL by serum free light chain (FLC) assay
- Serum M-protein level >= 2 gm/dL
- Presence of t(4;14) or del 17p, del 13q or 1q gain by conventional cytogenetics or fluorescence in situ hybridization (FISH) studies.
- >20% plasma cells on biopsy or aspirate
- Bone marrow aspirate and/or biopsy is required to be performed within 42 days prior to randomization and must demonstrate 10-59% clonal plasma cells.
- >= 1 g/dL on serum protein electrophoresis (within 28 days prior to randomization).
>= 200 mg of monoclonal protein on a 24 hour urine protein electrophoresis (within 28 days prior to randomization).
- NOTE: In the rare situation where the serum protein electrophoresis (SPEP) is felt to be unreliable, then quantitative immunoglobulin levels on nephelometry or turbidometry can be accepted.
SPEP, urine protein electrophoresis (UPEP), and serum FLC are required to be performed within 28 days prior to randomization.
- NOTE: UPEP (on a 24-hour collection) is required; no substitute method is acceptable. Urine must be followed monthly if the baseline urine M-spike is >= 200 mg/24 hour (hr), and urine in addition to serum must be followed in order to confirm a very good partial response (VGPR) or higher response.
- Patients must have no lytic lesions, no known plasmacytoma, and no unexplained hypercalcemia (i.e., > 11 mg/dL or 1mg/dL above upper limit of normal [ULN]).
- Hemoglobin >= 11 g/dL (within 28 days prior to randomization).
- Platelet count >= 100,000 cells/mm^3 (within 28 days prior to randomization).
- Absolute neutrophil count >= 1500 cells/mm^3 (within 28 days prior to randomization).
- Calculated creatinine clearance >= 30 mL/min (within 28 days prior to randomization).
- Bilirubin =< 1.5 mg/dL (within 28 days prior to randomization).
- Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) and serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< 2.5 times the upper limit of normal (within 28 days prior to randomization).
- Patients must not have any prior or concurrent systemic or radiation therapy for the treatment of myeloma. Patients must also not have contraindication to deep vein thrombosis (DVT) prophylaxis/aspirin.
- Patients must not have more than one focal marrow lesion on magnetic resonance imaging (MRI) of either pelvis or spine. Patients with indwelling pacemakers and/or ICD (implantable cardioverter-defibrillator) that is known or suspected to be MRI incompatible will be excused from this test.
- Concurrent use of erythropoietin is not allowed while on study therapy.
- Prior or glucocorticosteroid therapy for the treatment of multiple myeloma is not permitted. Prior systemic glucocorticosteroid use for the treatment of non-malignant disorders is permitted; concurrent use after registration on the study should be restricted to the equivalent of prednisone 10 mg per day. Prior or concurrent topical or localized glucocorticosteroid therapy to treat non-malignant comorbid disorders is permitted.
- Patients must not have active, uncontrolled seizure disorder. Patients must not have had a seizure in the last 6 months.
- Patients must not have uncontrolled intercurrent illness including uncontrolled hypertension, symptomatic congestive heart failure, unstable angina, uncontrolled cardiac arrhythmia, uncontrolled psychiatric illness or social situation that would limit compliance with the study, or a prior history of Stevens Johnson syndrome.
- Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2.
- Patients with monoclonal gammopathy of undetermined significance are not eligible.
- Patients must not have grade 2 or higher peripheral neuropathy per CTCAE.
- Patients must not have active, uncontrolled infection.
- Patients may have a history of current or previous deep vein thrombosis or pulmonary embolism but are required to take some form of anti-coagulation as prophylaxis if they are not currently on full-dose anticoagulation.
- Patients should not have New York Heart Association classification III or IV heart failure at baseline.
- Patients with a history of prior malignancy are eligible provided they were treated with curative intent and have been free of disease for the time period considered appropriate for cure of the specific cancer. For most diseases this time frame is 5 years.
- Patients must agree to register into the mandatory Risk Evaluation and Mitigation Strategy (REMS) program and be willing and able to comply with the requirements of REMS.
- Women must not be pregnant due to potential harm to the fetus from daratumumab and lenalidomide. All females of childbearing potential (FCBP) must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to the first dose of lenalidomide and again within 24 hours prior to the first dose of lenalidomide. FCBP must also agree to ongoing pregnancy testing while on treatment. A female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy, or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months).
- Females of childbearing potential (FCBP) must either abstain from sexual intercourse for the duration of their participation in the study or agree to use TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting study treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 28 days after the last dose of protocol treatment (FCBP who are assigned to Arm A and receive daratumumab must extend this contraception requirement to 3 months after the last dose of protocol treatment). Women must also agree to not breastfeed during this same time period. Men must agree to either abstain from sexual intercourse for the duration of their participation in the study or use a latex condom during sexual contact with a FCBP while participating in the study and for 28 days after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 28 days after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment.
- Human immunodeficiency virus (HIV)+ patients with undetectable HIV viral loads tested within 6 months are eligible.
- Patients should not have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to daratumumab, lenalidomide, or dexamethasone.
- Patients must not have known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) <50% of predicted normal or known moderate or severe persistent asthma within 2 years prior to randomization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm I (daratumumab, lenalidomide, dexamethasone)
Patients receive daratumumab IV on days 1, 8, 15, and 22 of courses 1-2, days 1 and 15 of courses 3-6, and day 1 of courses 7-24.
Patients also receive lenalidomide PO daily on days 1-21 and dexamethasone PO on days 1, 8, 15, and 22 in courses 1-12.
Treatment repeats every 28 days for up to 24 courses in the absence of disease progression or unacceptable toxicity.
|
Ancillary studies
Given IV
Other Names:
Given PO
Other Names:
Given PO
Other Names:
|
Experimental: Arm II (lenalidomide, dexamethasone)
Patients receive lenalidomide PO daily on days 1-21 and dexamethasone PO on days 1, 8, 15, and 22 of courses 1-12.
Treatment repeats every 28 days for up to 24 courses in the absence of disease progression or unacceptable toxicity.
|
Ancillary studies
Other Names:
Ancillary studies
Given PO
Other Names:
Given PO
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall survival (OS)
Time Frame: From randomization to death due to any cause, or censored at date last known alive, assessed up to 15 years
|
Will be estimated using the Kaplan-Meier (KM) method and compared using a stratified log-rank test.
Stratified cox proportional hazards regression will produce a treatment hazard ratio estimate.
|
From randomization to death due to any cause, or censored at date last known alive, assessed up to 15 years
|
Functional Assessment of Cancer Therapy-General (FACT-G) score
Time Frame: Baseline to 24 cycles of treatment (each cycle is 28 days)
|
A general effect size measure of half standard deviation will be used to establish the minimally important difference.
Descriptive statistics (mean, standard deviation [SD], median, range) will be used to evaluate the distribution of levels and changes for the set of health-related quality of life (QOL) evaluations.
Levels and changes will also be assessed graphically.
Changes from baseline will be analyzed using linear mixed models based on restricted maximum likelihood estimation with covariance matrix maximizing Akaike information criteria.
Models with treatment, assessment time, and treatment by assessment time interaction with and without other predictors will be fit.
If there is substantial missingness, will analyze the data according to the methods described in Schluchter and Schluchter, Greene and Beck.
|
Baseline to 24 cycles of treatment (each cycle is 28 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Progression-free survival (PFS)
Time Frame: From randomization until disease progression or death due to any cause, or censored at date of last disease evaluation, assessed up to 15 years
|
Will be estimated using the KM method and compared using a stratified log-rank test.
Stratified cox proportional hazards regression will produce a treatment hazard ratio estimate.
|
From randomization until disease progression or death due to any cause, or censored at date of last disease evaluation, assessed up to 15 years
|
Best response on treatment based on International Myeloma Working Group (IMWG) criteria
Time Frame: At 12 and 24 months
|
Response will be tabulated by category.
Response rates of very good partial response (VGPR) or better and partial response (PR) or better will be compared using the Fisher's exact test.
Ineligible patients are excluded from the analysis and unevaluable patients are counted in the denominator.
|
At 12 and 24 months
|
Incidence of adverse events by worst grade and type for treated patients determined using Common Terminology Criteria for Adverse Events (CTCAE) version 5.0
Time Frame: Up to 28 days post-treatment
|
Will monitor the toxicities experienced by all treated patients.
Will compare rates of worst grade 3 or higher non-hematologic treatment-related events using the Fisher's exact test.
|
Up to 28 days post-treatment
|
Incidence of grade 3 or higher infusion-related reactions over course 1 determined based on CTCAE
Time Frame: During cycle 1 of treatment (each cycle is 28 days)
|
Will monitor the toxicities experienced by all treated patients.
Will compare rates of worst grade 3 or higher non-hematologic treatment-related events using the Fisher's exact test.
|
During cycle 1 of treatment (each cycle is 28 days)
|
Stem cell (SC) mobilization failure
Time Frame: After 4 to 6 cycles of treatment (each cycle is 28 days)
|
Defined as not collecting a minimum of 5x10^6 CD34 cells per kilogram weight.
SC mobilization and type of growth factor support will be summarized overall and by treatment arm with descriptive statistics.
|
After 4 to 6 cycles of treatment (each cycle is 28 days)
|
Early SC mobilization feasibility
Time Frame: Up to 6 cycles of treatment (each cycle is 28 days)
|
Defined as the proportion of patients less than 65 years of age treated for 6 courses who opt for SC mobilization.
SC mobilization and type of growth factor support will be summarized overall and by treatment arm with descriptive statistics.
|
Up to 6 cycles of treatment (each cycle is 28 days)
|
Type of growth factor support
Time Frame: During 4 to 6 cycles of treatment (each cycle is 28 days)
|
SC mobilization and type of growth factor support will be summarized overall and by treatment arm with descriptive statistics.
|
During 4 to 6 cycles of treatment (each cycle is 28 days)
|
Change in FACT-G score
Time Frame: From treatment end to 6 months post-treatment
|
A general effect size measure of half standard deviation will be used to establish the minimally important difference.
Descriptive statistics (mean, SD, median, range) will be used to evaluate the distribution of levels and changes for the set of health-related QOL evaluations.
Levels and changes will also be assessed graphically.
Changes from baseline will be analyzed using linear mixed models based on restricted maximum likelihood estimation with covariance matrix maximizing Akaike information criteria.
Models with treatment, assessment time, and treatment by assessment time interaction with and without other predictors will be fit.
If there is substantial missingness, will analyze the data according to the methods described in Schluchter and Schluchter, Greene and Beck.
|
From treatment end to 6 months post-treatment
|
Levels of FACT-G score at each assessment time point
Time Frame: From baseline, at 3, f7, 13, 19 cycles of treatment, and early discontinuation of treatment, assessed up to 24 cycles of treatment (each cycle is 28 days)
|
A general effect size measure of half standard deviation will be used to establish the minimally important difference.
Descriptive statistics (mean, SD, median, range) will be used to evaluate the distribution of levels and changes for the set of health-related QOL evaluations.
Levels and changes will also be assessed graphically.
Changes from baseline will be analyzed using linear mixed models based on restricted maximum likelihood estimation with covariance matrix maximizing Akaike information criteria.
Models with treatment, assessment time, and treatment by assessment time interaction with and without other predictors will be fit.
If there is substantial missingness, will analyze the data according to the methods described in Schluchter and Schluchter, Greene and Beck.
|
From baseline, at 3, f7, 13, 19 cycles of treatment, and early discontinuation of treatment, assessed up to 24 cycles of treatment (each cycle is 28 days)
|
Time to worsening of FACT-G
Time Frame: From baseline until a decrease of 9 points, or censored at date of last assessment, assessed up to 6 months post-treatment
|
Will be analyzed with Kaplan-Meier methods and Cox regression with the related treatment arm as the only factor.
Correlation between time to worsening of symptoms with PFS and OS will be assessed with Kendall's Tau adjusted for censored observations.
|
From baseline until a decrease of 9 points, or censored at date of last assessment, assessed up to 6 months post-treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PRO compliance rate
Time Frame: Up to 15 years
|
Defined as the proportion of patients who submit the given PRO instrument among those eligible at each time point which excludes those missing by design (due to death or disease progression, early treatment discontinuation).
|
Up to 15 years
|
PRO completion rate
Time Frame: Up to 15 years
|
Defined as the proportion of patients who complete given PRO instrument based on the instrument's scoring system among those eligible at each time point.
|
Up to 15 years
|
Cumulative dose calculated as the sum of all doses taken across all cycles
Time Frame: Up to 24 months
|
Cumulative dose will be calculated overall and by cycle.
Data will be summarized by treatment arm with descriptive statistics and graphically over time.
Patients will be classified into dichotomous groups based on a 75% relative dose intensity cutoff (< 75% versus [vs] >= 75% represents poor vs good treatment adherence).
The proportion of patients with poor lenalidomide treatment adherence will be compared between arms using the Fisher's exact test.
In addition, multi-variable logistic regression analysis will be conducted to identify the baseline factors associated with calculated good treatment adherence.
|
Up to 24 months
|
Dose intensity calculated as cumulative dose received divided by treatment duration
Time Frame: Up to 24 months
|
Dose intensity will be calculated overall and by cycle.
Data will be summarized by treatment arm with descriptive statistics and graphically over time.
Patients will be classified into dichotomous groups based on a 75% relative dose intensity cutoff (< 75% vs >= 75% represents poor vs good treatment adherence).
The proportion of patients with poor lenalidomide treatment adherence will be compared between arms using the Fisher's exact test.
In addition, multi-variable logistic regression analysis will be conducted to identify the baseline factors associated with calculated good treatment adherence.
|
Up to 24 months
|
Relative dose intensity calculated as the dose intensity divided by planned dose intensity
Time Frame: Up to 24 months
|
Dose intensity will be calculated overall and by cycle.
Data will be summarized by treatment arm with descriptive statistics and graphically over time.
Patients will be classified into dichotomous groups based on a 75% relative dose intensity cutoff (< 75% vs >= 75% represents poor vs good treatment adherence).
The proportion of patients with poor lenalidomide treatment adherence will be compared between arms using the Fisher's exact test.
In addition, multi-variable logistic regression analysis will be conducted to identify the baseline factors associated with calculated good treatment adherence.
|
Up to 24 months
|
Duration of treatment
Time Frame: From randomization to date off treatment, or censored at the date of last treatment, assessed up to 24 months
|
Treatment duration in each arm will be estimated using Kaplan-Meier methods and compared between arms with the log-rank test.
|
From randomization to date off treatment, or censored at the date of last treatment, assessed up to 24 months
|
Time to progression
Time Frame: From randomization to progression, or censored at date of last disease evaluation, assessed up to 15 years
|
Will be estimated using the Kaplan-Meier method.
|
From randomization to progression, or censored at date of last disease evaluation, assessed up to 15 years
|
Presence, frequency, interference, amount and/or severity of select patient reported outcomes (PRO)-CTCAEs
Time Frame: Assessed at each treatment cycle, from cycle 1 of treatment to end of treatment, up to 24 cycles of treatment (each cycle is 28 days)
|
Descriptive statistics (mean, standard deviation, median, range) will be used to summarize selected PRO-CTCAEs tabulated at each cycle overall and by arm.
Will map PRO-CTCAEs with provider reported adverse events (AEs) and evaluate differences in incidence and worst severity.
Items correspond to 5 attributes measured [frequency (F), severity (S), interference (I), presence/absence (P) and amount (A)] based on multiple choice questions.
Response for each attribute except P which is binary is on a 5-point Likert scale with 5 indicating 'almost constantly' frequency, 'very severe' severity, 'very much' amount or 'very much' interference.
An overall PRO-CTCAE score will be calculated at each time point.
|
Assessed at each treatment cycle, from cycle 1 of treatment to end of treatment, up to 24 cycles of treatment (each cycle is 28 days)
|
Overall PRO-CTCAE score
Time Frame: Up to 15 years
|
Defined as the sum of item scores on all symptomatic adverse events (AEs).
Descriptive statistics will be used to summarize selected PRO-CTCAEs tabulated at each cycle overall and by arm.
Will map PRO-CTCAEs with provider reported AEs and evaluate differences in incidence and worst severity.
An overall PRO-CTCAE score will be calculated at each time point.
|
Up to 15 years
|
Adherence Starts with Knowledge (ASK)-12 scores
Time Frame: At 7, 13, and 19 cycles of treatment (each cycle is 28 days)
|
Descriptive statistics will be used to summarize ASK-12 scores tabulated at cycles 7, 13 and 19 overall and by arm.
Differences between arms will be evaluated based a t-test (or Wilcoxon rank sum test).
Patients will also be classified into high versus low likelihood of medication adherence groups according to tertile distributions (lowest tertile vs second and top).
Association between likelihood of medication adherence and calculated treatment adherence dichotomous groups will be evaluated in patients with both ASK-12 and treatment data at cycles 7, 13 and 19 post randomization.
In addition, multivariable logistic regression analysis will be conducted to identify the baseline factors associated with low likelihood of medication adherence.
|
At 7, 13, and 19 cycles of treatment (each cycle is 28 days)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Natalie S Callander, ECOG-ACRIN Cancer Research Group
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Immune System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Lymphoproliferative Disorders
- Immunoproliferative Disorders
- Hematologic Diseases
- Hemorrhagic Disorders
- Hemostatic Disorders
- Paraproteinemias
- Blood Protein Disorders
- Precancerous Conditions
- Hypergammaglobulinemia
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Smoldering Multiple Myeloma
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Immunologic Factors
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Protease Inhibitors
- Angiogenesis Inhibitors
- Angiogenesis Modulating Agents
- Growth Substances
- Growth Inhibitors
- Dermatologic Agents
- Dexamethasone
- Dexamethasone acetate
- BB 1101
- Lenalidomide
- Daratumumab
- Ichthammol
Other Study ID Numbers
- EAA173 (Other Identifier: CTEP)
- U10CA180820 (U.S. NIH Grant/Contract)
- NCI-2018-02611 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoldering Plasma Cell Myeloma
-
Mayo ClinicActive, not recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Roswell Park Cancer InstituteRecruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
University of Colorado, DenverTerminatedPlasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell Myeloma | PlasmacytosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingSmoldering Plasma Cell MyelomaUnited States
Clinical Trials on Quality-of-Life Assessment
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood Malignant NeoplasmUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Malignant Ovarian Epithelial Tumor | Ovarian Carcinosarcoma | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingCervical Carcinoma | Endometrial Carcinoma | Vaginal Carcinoma | Malignant Female Reproductive System Neoplasm | Vulvar CarcinomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Neuropathy | COVID-19 InfectionUnited States